Aceragen Inc (ACGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 98,091 | 102,210 | 108,175 | 115,738 | -112,662 |
| Depreciation Amortization | 22 | 17 | 11 | 6 | 61 |
| Other Working Capital | 388 | 895 | 106 | -726 | -1,118 |
| Other Operating Activity | -123,098 | -123,667 | -124,142 | -124,609 | 79,947 |
| Operating Cash Flow | $-24,597 | $-20,545 | $-15,850 | $-9,591 | $-33,772 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,500 | 4,500 | 4,500 | 4,500 | -1,679 |
| PPE Investments | N/A | N/A | N/A | N/A | -8 |
| Investing Cash Flow | $4,500 | $4,500 | $4,500 | $4,500 | $-1,687 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -217 |
| Common Stock Issued | 330 | 319 | 305 | 299 | 128 |
| Other Financing Activity | 19,083 | 19,099 | 18,406 | 16,104 | 28,758 |
| Financing Cash Flow | $19,413 | $19,418 | $18,711 | $16,403 | $28,669 |
| Beginning Cash Position | 33,229 | 33,229 | 33,229 | 33,229 | 40,019 |
| End Cash Position | 32,545 | 36,602 | 40,590 | 44,541 | 33,229 |
| Net Cash Flow | $-684 | $3,373 | $7,361 | $11,312 | $-6,790 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,597 | -20,545 | -15,850 | -9,591 | -33,772 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -8 |
| Free Cash Flow | -24,597 | -20,545 | -15,850 | -9,591 | -33,780 |